The effect of brief self-management intervention for hemodialysis patients (HED-SMART) on trajectories of depressive and anxious symptoms by Griva, K. et al.
              
City, University of London Institutional Repository
Citation: Griva, K., Lam, K. F. Y., Nandakumar, M., Ng, J. A. H., McBain, H. B. ORCID: 
0000-0002-6742-1104 and Newman, S. P. ORCID: 0000-0001-6712-6079 (2018). The effect 
of brief self-management intervention for hemodialysis patients (HED-SMART) on 
trajectories of depressive and anxious symptoms. Journal of Psychosomatic Research, 113, 
pp. 37-44. doi: 10.1016/j.jpsychores.2018.07.012 
This is the accepted version of the paper. 
This version of the publication may differ from the final published 
version. 
Permanent repository link:  http://openaccess.city.ac.uk/20265/
Link to published version: http://dx.doi.org/10.1016/j.jpsychores.2018.07.012
Copyright and reuse: City Research Online aims to make research 
outputs of City, University of London available to a wider audience. 
Copyright and Moral Rights remain with the author(s) and/or copyright 
holders. URLs from City Research Online may be freely distributed and 
linked to.
City Research Online:            http://openaccess.city.ac.uk/            publications@city.ac.uk
City Research Online
DEPRESSION & ANXIETY TRAJECTORIES IN HED-SMART 
 
1 
 
Title: 
The Effect of Brief Self-Management Intervention for Hemodialysis Patients (HED-SMART) 
on Trajectories of Depressive and Anxious Symptoms 
Short Title (for Running Head):   
Depression & Anxiety Trajectories in HED-SMART 
Authors: 
Konstadina Griva, Ph.D,1,3 Kevin F. Y. Lam, B.Soc.Sci,1 Mooppil Nandakumar, MRCP 
(UK),2 Jo-an H. Ng, B.Soc.Sci, 1 Hayley McBain, Ph.D,3 4 Stanton P Newman, D.Phil3  
1 Department of Psychology, National University of Singapore, 9Arts Link AS4 02/28, 
Singapore 117570. 
2 National Kidney Foundation, 81 Kim Keat Road, Singapore 328836.  
3 School of Health Sciences, City, University of London, Northampton Square, London, UK.  
4 Community Health Newham, East London NHS Foundation Trust, 9 Alie Street, 
London, UK 
Corresponding Author: 
A/P Konstadina Griva, Centre for Population Health Sciences, Lee Kong Chian School of 
Medicine, Nanyang Technological University, Clinical Sciences Building, Singapore 308232, 
Singapore. Email: konstadina.griva@ntu.edu.sg; Phone: 69047348 
 
Word Count (Abstract):  250 words 
Word Count (Body): 3669 words 
 
  
  
DEPRESSION & ANXIETY TRAJECTORIES IN HED-SMART 
 
2 
 
Abstract 
Objective: Depression is often comorbid with End-Stage Renal Disease, and associated with 
poor adherence and clinical outcomes but course of symptoms is variable. This study sought 
to describe the long-term trajectories of anxiety and depression in hemodialysis patients, to 
identify predictors of these trajectories over 12 months and to evaluate the effectiveness of 
the HEmoDialysis Self-Management Randomized Trial (HED SMART) against usual care on 
symptoms of anxiety and depression. 
Methods: A secondary analysis of data from a randomized controlled trial that contrasted 
HED SMART (n=101) against usual care (n=134). Depressive and anxious symptoms were 
assessed using the Hospital Anxiety and Depression Scale (HADS) at baseline, 1 week and at 
3 and 9 months post-intervention. Latent class growth analysis identified trajectories of 
depression and anxiety, and their sociodemographic and clinical predictors. 
Results: Symptoms of depression and anxiety over 12 months were characterized by two 
trajectories: low stable (depression: 55%; anxiety: 59%) with non-clinical levels of distress, 
and high stable (depression: 45%; anxiety: 41%) with clinical levels of distress. HED 
SMART predicted significant reductions in depression relative to usual care. A similar trend 
was noted for anxiety. Younger age, Chinese ethnicity, and more comorbidities were 
associated with persistent high depression. Younger age and shorter dialysis vintage was 
associated with persistent high anxiety. 
Conclusion: A brief self-management intervention designed to support behavioral change 
can also lead to significant reductions in symptoms of depression and may be of great value 
for younger HD patients shown to be at greater risk for persistent distress. 
 
Keywords: depression; hemodialysis; trajectories; intervention  
Trial registration: ISRTN31434033 
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The Effect of Brief Self-Management Intervention  
for Hemodialysis Patients on Trajectories of Depressive and Anxious Symptoms  
 
Depression is a frequent and pernicious comorbid condition amongst patients with 
End Stage Renal Disease (ESRD), with prevalence rates between 23% to 29% [1,2]. 
Estimates of subclinical distress, using self-report measures rather than diagnostic 
assessments, are even higher.  Most research, however, has measured distress at one time. Of 
the limited longitudinal research that has been conducted, it has been established that 
symptoms of distress vary markedly across patients with respect to their severity, longitudinal 
course and response to treatment [3,4]. It is important to understand symptom course and 
individual variability to guide more targeted intervention efforts in ESRD.  
 Support programs for ESRD related distress are much needed as symptoms of 
emotional distress have been shown to be associated with poor clinical outcomes, including 
higher morbidity and mortality rates, and higher health care costs [5,6]. Studies have also 
noted that trends over time (i.e., persisting or worsening of symptoms over time) are 
associated with increased cardiovascular and overall mortality risk [7,8]. Small-scale 
randomized controlled trials of Cognitive Behavioral Therapy (CBT), an evidence-based 
treatment for depression, have been shown to reduce distress in patients on dialysis [9,10]. 
Considerations  however, related to high costs, intensity and the need for additional resources 
(e.g., specialist CBT therapists) for CBT programs coupled with a shortage of healthcare staff 
with psychological skills training constrain their availability and wide implementation in 
routine renal care [11]. 
 Self-management based programs have been widely advocated as an effective and 
cost-efficient means to deliver patient education and provide patients with self-management 
skills and strategies to promote and change their behavior as well increase their confidence in 
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dealing with their long-term condition [12]. In ESRD, such programs, delivered and 
implemented by health care staff have demonstrated improvements in several outcomes 
including self-efficacy [13], quality of life [14], and self-report adherence and clinical 
markers [15]. 
Although it is generally hoped that broader benefits may also be achieved, little is 
known about the effectiveness of these interventions in reducing distress. This raises the 
question of whether these less resource-intensive interventions, where the focus is mainly on 
behavioral change, would bring about other gains notably in mental health. This is 
particularly pertinent in Asian settings where the stigma attached to mental health and 
related-services may hinder the acceptability, participation or retention in CBT programs 
[16–18]. The HED-SMART intervention (HEmoDialysis Self-Management Randomized 
Trial) is a brief self-management intervention developed through formative work in 
Singapore to improve treatment adherence and clinical outcomes in ESRD [15,19]. Delivered 
by renal health professionals over 4 group sessions, the program was designed to support 
behavior change using the principles of Social Learning Theory, self-monitoring, and goal 
setting. Analyses of primary outcomes indicated significant benefits for HED-SMART in 
clinical markers, namely interdialytic weight gains (markers of fluid control) and potassium 
and phosphate levels with only modest loss of effects at nine months post intervention [15]. 
The aims of the present study were (1) to identify the trajectories of depressive and 
anxious symptoms over 12 months (2) to examine the effects sociodemographic and medical 
parameters on these trajectories and (3) to evaluate the effects of HED-SMART on the course 
of these emotional outcomes. 
Methods 
Study Design 
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The data presented in this paper are part of the Hemodialysis Self-Management 
Randomized Trial (HED-SMART), a pragmatic cluster RCT (Trial Registration: 
ISRTN31434033), which used dialysis shift within each dialysis center as the unit of 
randomization. The methods have been described in detail previously [15]. In summary, this 
is a 12 month 2-group randomised controlled trial, to compare the HED SMART intervention 
in addition to usual care, with usual care alone. Study endpoints included clinical markers of 
disease control, i.e. interdialytic weights gain, potassium, phosphate levels and patient-
reported outcomes, i.e. adherence, self-efficacy, self-management skills, quality-of-life and 
distress collected at baseline, and at 2 weeks, 3 months and 9-month follow up. The primary 
objectives of the trial were to determine if this brief group-based self-management 
intervention could improve short- and long-term, self-management skills, behavioral and 
clinical outcomes [15]. Part of the secondary objectives which constitute the foci of this 
paper, were to determine the impact of this intervention on psychological outcomes.  
 
Setting and Participants 
The trial was undertaken between 2009 to 2013. The recruiting centers were dialysis 
centers operated by National Kidney Foundation (NKF), Singapore. NKF Singapore is a 
nonprofit charitable organization that caters for the lower and middle-income patients with 
ESRD in Singapore. NKF Singapore dialysis centres are located within the community, 
island wide, and run by nurses with a team of nephrologists working in rotation. The target 
population comprised adults, aged 21 years and above, receiving hemodialysis in one of the 
11 participating National Kidney Foundation dialysis centers in Singapore for a minimum 
duration of six months. Participants were excluded if they were not fluent in either English, 
Mandarin or Malay, or had conditions that would hinder full participation in the trial (i.e., 
functional psychosis, organic brain disorder), learning disabilities, dementia, life-limiting 
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medical disorders or significant hearing or visual impairments uncorrected with hearing or 
visual aids). Inclusion/ exclusion criteria were assessed by senior nurse through patients’ 
medical records.  
Recruitment and Randomization  
 Patients were randomly allocated to the intervention or control condition based on 
their dialysis shifts to minimize contamination across patients within the same shift. Those in 
the intervention condition received HED-SMART over and above standard renal care, while 
those in the control condition received only standard renal care. Patients were informed of the 
results of the randomization only after having provided informed consent and completing the 
baseline assessment. All staff at the dialysis centers, and research personnel administering the 
questionnaires, remained blind to patients’ study arm allocation (Figure 1).  
The intervention was then implemented at 3 weeks post-baseline, in a group format 
over 3 core sessions (1 to 3)  and 1 booster session [19]. HED-SMART was guided by social 
cognitive theory and aimed to improve capability for disease management. Sessions targeted 
knowledge, attitudes, skills and self-management behaviours: fluid intake, diet and 
medication.  The content and delivery format was established following rigorous process 
including focus groups and interviews, training and extensive piloting to develop a theory-
based program that is tailored to needs of patients in local context [20]. The sessions were 
delivered in groups of 5-7 patients, in either English, Chinese or Malay (as per patients’ 
preference). They were facilitated by two renal health professionals (medical social worker, 
renal dietician or nurse) unrelated to direct patients’ care and took place over weekends (non-
dialysis days) to avoid interference with dialysis center workflow and to allow more 
flexibility in patients’ and facilitators’ availability. Non-dialysis days were also preferred as 
cognitive abilities over dialysis cycle are shown to be better at 24-hours post dialysis [21]. 
Measures  
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Sociodemographic information, including age, gender, ethnicity, employment status, 
education, and marital status, were collected at baseline. Medical/serological data, including 
Kt/V, nPCR, hemoglobin, albumin, comorbidities, primary cause of ESRD, and duration of 
hemodialysis (in months), were abstracted from medical records. The Charlson Comorbid 
Index (CCI) [22] was used to consolidate co-morbidity burden, and subsequently scored 
based on previous recommendations [23]. Higher scores indicate greater comorbid burden. 
The CCI has been validated for use in ESRD patients [24]. 
Emotional distress was measured using the Hospital Anxiety and Depression Scale 
(HADS) [25], a well-established self-report measure of anxiety and depression. The HADS 
was selected not only because its omission of somatic items makes it an appropriate measure 
for a chronically ill population, but also because it has been linguistically validated in both 
Mandarin [26] and Malay [27], an important consideration for use in the multi-ethnic context 
of Singapore. HADS assesses symptoms of anxiety (7 items; score range=0 to 21) and 
depression (7 items; score range=0 to 21) within the past week. Higher scores indicate higher 
levels of depressive and anxious symptoms – with scores ≥ 8 for each subscale signifying 
caseness as per internationally validated criteria across a range of patient populations and 
cultures [28,29]. In the present study, both the HADS-D and HADS-A demonstrated good 
internal consistency across all assessments (αs > .70). Participants self-completed the study 
questionnaire. The researcher provided assistance when required.   
Emotional distress was measured at baseline (Time 1), immediately after the end of 
HED-SMART (Time 2; 1week post), and at 3 months (Time 3), and at 9 months (Time 4) 
post-HED-SMART.   
Data Analysis 
Latent Class Growth Analysis (LCGA) [30,31] was employed using Mplus version 
6.12 [32]. Unlike conventional growth curve modelling [33], LCGA does not assume that all 
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individuals within the sample can be adequately characterized by a single set of growth 
parameters (i.e., intercepts and slopes) [34]. As such, this technique allows researchers to 
examine if a population comprises multiple growth trajectories [34], and to subsequently 
model covariates as predictors of trajectory membership and growth parameters [35].  
Unconditional model. To select the optimal number of trajectories, one through four 
classes of linear growth models were fit without covariates in a series of iterative steps 
[36,37]. Based on previous recommendations, this selection was guided by substantive 
interpretation [38] and the following fit statistics [39]: Bayesian Information Criterion (BIC) 
[40] and Bootstrapped Likelihood Ratio Test (BLRT) [41,42]. Lower BIC, and significant 
BLRT, values indicate better model fit. However, if the lowest BIC value corresponded to the 
model with the largest number of classes, “elbow” plots were examined in a method similar 
to the use of scree plots in Exploratory Factor Analysis (EFA) [36]. Entropy, a measure of 
classification quality, was also obtained. Its values range from zero to one, and values closer 
to one indicate better classification of individuals into classes [36,43]. The resultant linear 
growth model was compared against a corresponding quadratic growth model using χ2 
difference tests to investigate if the inclusion of a quadratic growth parameter would 
significantly improve model fit [37].  
Conditional model. To model covariates as predictors of trajectory membership and 
growth parameters, selected sociodemographic and medical variables, and the intervention 
variable, were included into the unconditional model [37]. Class membership was regressed 
on key sociodemographic and medical variables. Given the risk for model instability as result 
of too many covariates [44], only the following variables, shown to be significantly 
associated with depression or anxiety in previous work on hemodialysis (HD), were included: 
age, gender, ethnicity, education, dialysis vintage, and co-morbidity burden. The linear 
growth factor within each class was also regressed on the dummy-coded intervention variable 
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(1 = intervention; 0 = usual care). In order to determine if the intervention effect varied 
according to latent class membership, χ2 difference tests were employed to compare (a) a 
model in which the intervention effect was invariant across latent classes, against (b) a model 
in which the intervention effect was constant across latent classes.  
Missing Data 
The Mplus software package used Full Information Maximum Likelihood (FIML) 
estimation. This approach has been widely regarded as appropriate for handling missing data 
[45,46], and assumes that the data were Missing At Random (MAR) [47]. In order to assess 
the appropriateness of this assumption, sensitivity analyses were conducted to compare the 
LCGA model against a pattern mixture model in which the data were Not Missing At 
Random (NMAR) [48]. These analyses suggested the appropriateness of the MAR 
assumption: there were no significant improvements in the BIC for both depressive 
symptoms and anxious symptoms, and the trajectories remained substantively unchanged. 
Results 
Participants 
Figure 1 shows a flowchart of the recruitment process. Of the 956 patients screened 
between January 2009 and June 2012, 532 patients fulfilled the criteria, and were therefore 
invited to participate. Among these patients, 235 provided informed consent and completed 
the baseline assessment (response rate: 44%). These patients were subsequently randomized 
to either the HED-SMART intervention (n = 101) or usual care (n = 134) based on their 
dialysis shifts. Across the subsequent follow-up assessment points over the ensuing 12 
months, 91% (n = 214) were captured at Time 2; 88% (n = 206) at Time 3; and 82% (n = 
193) at Time 4. A total of 80% (n = 189) were captured across all four time points. 
[Insert Figure 1] 
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Table 1 shows the baseline sociodemographic and medical characteristics based on 
participants’ trial arm allocation. These characteristics, including emotional distress, were 
adequately balanced across both arms (no significant difference noted). On average, 
participants were 53.5 ± 10.4 years of age. Approximately 41.7% were female, and 56.8% 
identified as Chinese. Mean dialysis adequacy and biochemical markers were within accepted 
clinical targets [49], and CCI was moderate [23].  
[Insert Table 1] 
Symptoms of Depression 
Unconditional model. According to the fit indices in Table 2, successive linear 
growth models continued to demonstrate improved fit through four classes. An examination 
of the “elbow” plot for the BIC revealed a bend at two classes, which suggested that the two-
class solution fit the data best. Comparing the four- and two-class solutions, the former was 
relatively uninformative because it merely split each of the trajectories from the two- class 
solution based on intercept values. Therefore, based on a combination of statistical indicators 
and substantive interpretation, the four-class solution was rejected in favor of the two-class 
solution. The inclusion of a quadratic growth parameter did not significantly improve model 
fit (χ2 [2, N = 235] = .34, p = 0.85). 
Conditional model. After having identified the optimal number of trajectories, the 
seven sociodemographic and medical variables, as well as the intervention variable, were 
included in the unconditional model. The inclusion of the sociodemographic and medical 
variables significantly improved model fit (χ2 [7, N=218] = 120.45, p < 0.001), although the 
sample size was slightly reduced due to missing data on these covariates. A model in which 
the intervention effect varied across latent classes did not fit the data significantly better than 
a model in which the intervention effect was constant (χ2 [1, N = 218] = 1.44, p = 0.23). As 
shown in Figure 2, the two-class solution identified two substantively distinct groups of 
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trajectories of depressive symptoms. The first class (n = 120; 55%) was characterized by 
consistently low levels of depressive symptoms. This class was thus termed the low stable 
class. The second class (n = 98; 45%) was characterized by consistently high levels of 
depressive symptoms. This class was thus termed the high stable class.  
[Inset Figure 2] 
The results indicated that age, ethnicity, and comorbid burden significantly predicted 
latent class membership (Table 4): patients who were either younger, Chinese, or had higher 
CCI scores, were more likely to demonstrate the high stable, as compared to the low stable, 
trajectory of depressive symptoms. The intervention was also associated with a statistically 
significant reduction in symptoms of depression, over 12 months, in both the low stable and 
the high stable classes (B = -1.44, SE = 0.64, p = 0.03; Figure 2).  
Dialysis vintage was not associated with depression trajectories. 
Symptoms of Anxiety 
Unconditional model. A similar model-fitting process was followed for symptoms of 
anxiety. In line with the findings for symptoms of depression, the two-class model was 
selected based on an examination of the “elbow” plot for the BIC, and because the four-class 
solution was relatively uninformative as it merely split each of the trajectories from the two-
class solution based on intercept values. The inclusion of a quadratic growth parameter did 
not significantly improve model fit (χ2 [2, N = 235] = 1.84, p = 0.40).  
Conditional model. The inclusion of the same sociodemographic and medical 
variables further improved model fit (χ2 [7, N = 218] = 123.54, p < 0.001). A model in which 
the intervention effect varied across latent classes did not fit the data significantly better as 
compared to one in which the intervention effect was constant (χ2 [1, N = 218] = 0.013, p = 
0.91). As shown in Figure 2, the two-class solution identified two substantively distinct 
groups of trajectories of anxious symptoms. The first class (n = 129; 59%) was characterized 
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by consistently low levels of anxious symptoms. This class was thus termed the low stable 
class. The second class (n = 89; 41%) was characterized by consistently high levels of 
anxious symptoms. This class was thus termed the high stable class. 
 The findings indicated significant effects of age and dialysis vintage (Table 4). 
Patients who were either younger, or had a shorter dialysis vintage, were more likely to 
demonstrate the high stable, as compared to the low stable, trajectory of anxious symptoms. 
The intervention was also associated with a marginal reduction in symptoms of anxiety, over 
12 months, in both the low stable and the high stable classes – but the effect did not reach 
statistical significance (B = -1.23, SE = 0.65, p = 0.06; Figure 2). 
Discussion 
Depression and anxiety are growing health concerns in ESRD.  However, the majority 
of previous studies are observational, and have not examined the heterogeneity in the course 
of change in symptoms. To the best of our knowledge, the present study is the first to show 
distinct trajectories of depressive and anxious symptoms within the context of an RCT and 
the effects of a self-management intervention on these symptoms. 
Study findings showed that symptoms of anxiety and depression over 12 months 
follow two distinct courses. In each case a low stable class (i.e., no depression [55%]; no 
anxiety [59%]) characterized by consistently low symptoms within the normal range or below 
cut offs for a clinical classification. Second a high stable class characterized by persistently 
high symptoms of depression (45%) or anxiety (41%) throughout the 12-month study 
window. Previous studies have also noted this polarized pattern of few or no symptoms of 
distress or high distress in HD patients [4,50]. However, these findings differ from prior work 
on incident HD patients which identified low-reducing (62%), moderate-increasing (22%), 
and high-reducing (16%) trajectories for depression [3]. Nonetheless, because the 
abovementioned study comprised incident HD patients while the present study examined 
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prevalent patients, and because fluctuations in emotional distress tend to stabilize over time 
[51], it is possible that both the moderate-increasing and the high-reducing classes may 
eventually collapse into one of the two classes identified for the established HD patients in 
our study.  
Analyses found a range of variables that distinguished the trajectory groups. Patients 
who were either younger, Chinese, or had a greater number of co-morbidities, were more 
likely to demonstrate a high stable, as compared to a low stable, trajectory of depressive 
symptoms. Trajectories of anxious symptoms were predicted by age and dialysis vintage with 
patients who were either younger or had a shorter dialysis vintage more likely to demonstrate 
a high stable, as compared to a low stable, trajectory of anxious symptoms. These variables 
have not been included in other trajectory studies although some, namely age and comorbid 
burden have been found by some to be related to depression or anxiety [3,52]. Life on 
dialysis may be particularly disruptive for younger patients who are more likely to be 
occupationally active, in pursuit of life/personal goals, or with responsibilities towards family 
and dependents [3]. Culture-related views and stigma around mental health may explain the 
effects of ethnicity [16] found in this study. The Chinese culture traditionally views mental 
illnesses as weaknesses of character, those who hold these beliefs might be less likely to 
engage in help-seeking behavior, and are therefore at an increased risk of depression [17]. 
Familialism and collectivism beliefs, dominant among Chinese, may also intensify 
perceptions of burden and emotional distress when in ill health especially in local context of 
decreasing household sizes among Singaporean Chinese [53]. Similar effects have been noted 
for emotional QOL in cohort studies in Singapore [54] favoring Malay respondents (noted to 
have larger household sizes) over Chinese or Indian despite their lower socioeconomic 
resources and worse clinical profile. Although replication of these findings is essential, these 
analyses suggest that individual-level factors (e.g., younger age, Chinese ethnicity) appear to 
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be predictive of persistently high depressive and anxious symptoms – and could serve to 
identify at risk populations to be targeted.  
Study findings showed that the HED-SMART intervention, despite focusing primarily 
on behavior change, yielded significant benefits by reducing symptoms of depression for both 
the low stable and high stable groups. This has been shown for self-management programs in 
other patient group [55]. A similar trend was noted for reduced anxiety, although this failed 
to reach significance. These patterns of results provide preliminary support that theory-
informed self-management programs which extend the role of renal health care professionals 
to deliver minimal psychologically-informed behavior change interventions may also be 
useful in improving emotional distress and psychosocial adjustment. It is noteworthy that 
improvements were noted across all the trajectories. 
It is interesting to speculate how the emotional gains may have been brought about, 
especially as there was no component in HED-SMART to directly target emotional 
management. Although the mechanisms of these effects were not examined, several pathways 
are possible and suggest directions for future studies. First, HED-SMART might have 
impacted patients’ depressive symptoms by building personal resources (self-management 
skills; self-efficacy) that promote resilience, adherence to treatment and in turn improved 
clinical outcomes as shown in (15). HED SMART has shown benefits in clinical markers and 
adherence behaviors (15). These may in turn have lowered distress by reducing symptoms 
such as breathlessness or itchiness due to poor fluid intake or phosphate control (15) or 
reinforcing more adaptive attitudes towards illness and treatment. Such improvements may 
also translate to improved or more rewarding doctor-patient interactions as they imply less 
need for discussions related to adherence lapses that could generate distress and tension to 
patients. Moreover, better disease management, as shown in clinical endpoints may have 
provided further positive reinforcement for adaptive behaviors (e.g., self-care) [15]. Such 
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changes would be expected to lessen depressive symptoms by decreasing helplessness and 
hopelessness and further increasing self-efficacy.   
Second, participation in group-based HED-SMART might have created more 
opportunities for more effective peer support among patients and greater attention from 
healthcare professionals. These newly forged or more consistent relationships among HED-
SMART participants and facilitators might have provided additional social reinforcement and 
stress-buffering social support, both of which would be expected to reduce depressive 
symptoms [4]. Other processes (i.e., social comparisons or modelling) may also be involved 
in the observed psychological benefits. Considering the evidence on adverse effects of ESRD 
and hemodialysis on social life and activities [56], the potential of group-based intervention 
to build or expand interpersonal resources should be noted. 
There are several strengths to the present analyses. These include an adequately 
powered, RCT design, the recruitment of ethnically diverse representative sample of patients, 
a wide range of demographic and clinical parameters as predictors of latent class 
membership, as well as the employment of formal statistical models to identify 
heterogeneous trajectories of change. 
Nevertheless, some limitations should be mentioned. First, a convenience sample 
rather than a probability-based sample was used, which may limit generalizability to other 
populations. Although the current sample represents fairly well the national HD registry [57], 
the rate of diabetes was lower in this sample. The ethnic profile of sample differs from other 
cohorts such as the US Renal Data System (USRDS) that includes other ethnic groups not 
represented in our study sample. Replication is therefore warranted. Second, even though 
participants were randomly selected, self-selection bias by patients cannot be excluded. 
Although HADS is a validated measure and has been linguistically validated in both 
Mandarin [26] and Malay [27], its effectiveness as a screening tool for anxiety disorders has 
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been criticized [58]. Moreover, as no data were collected beyond 12 months post baseline, the 
longer-term trajectories, and effects of HED-SMART, are therefore not known. Last, 
although statistically significant effects were noted, their clinical relevance warrants further 
evaluation as minimal important difference in HADS has not been established. It is however 
encouraging that a brief, low intensity psychological intervention showed reduction in 
severity of depression and anxiety symptoms. 
In conclusion, this study is the first to use a formal statistical model such as LCGA to 
assess emotional distress trajectories in a cohort of prevalent HD patients in Singapore. The 
findings indicated two markedly distinct classes of symptom progression that remained stable 
over time. Further analyses revealed that HED-SMART, a brief, low intensity self-
management intervention designed to support behavior change, led to reductions in 
depressive and anxious symptoms, and could be of great value for younger patients shown to 
be at a greater risk for persistent distress. Given the high prevalence of primary/illiterate 
education status (>25%) in our sample, the HED-SMART intervention may also be well 
suited for populations with low health literacy. 
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Table 1.  
 
Participants’ Characteristics 
 
    
  
  
Total sample 
(N=235) 
HED-SMART 
(n=101) 
Usual Care 
(n=134) 
p 
Age (years) 53.5 ± 10.4 53.1 ± 10.5 53.9 ± 10.4 0.5a 
Age at diagnosis (years) 43.4 ± 13.5 42.9 ± 13.3 43.7 ± 13.8 0.7a 
Age when left formal education, 
(years) 
16.7 ± 6.0 17.1 ± 7.4 16.4 ± 4.7 0.3a 
Education level    0.1b 
Illiterate/primary 71 (30.2%) 28 (27.7%) 43 (32.1%)  
Secondary 147 (62.6%) 69 (68.3%) 78 (58.2%)  
Tertiary 17 (7.2%) 4 (4%) 51 (38.3%)  
Female sex 98 (41.7%) 47 (46.1%) 51 (38.3%) 0.3b 
Ethnicity    0.9b 
• Chinese 133 (56.8%) 57 (55.9%) 76 (57.6%)  
• Malay 80 (34.2%) 36 (35.3%) 44 (33.3%)  
• Indian 15 (6.4%) 7 (6.9%) 8 (6.1%)  
• Others 6 (2.5%) 2 (2%) 4 (3.1%)  
Relationship status: married 155 (66.5%) 68 (67.3%) 87 (65.9%) 0.9b 
Employment status: employedc 87 (42.6%) 33 (37.5%) 54 (46.6%) 0.2b 
Perceived ability to work (able)  129 (56.8%) 52 (51.0%) 77 (61.6%) 0.1 b 
Incomed,e    0.1e 
• S$0- S$2,000 119 (51.5%) 59 (58.4%) 60 (46.2%)  
• S$2,001 - S$4,000 49 (21.2%) 16 (15.8%) 33 (25.4%)  
• S$4,001 - S$6,000 11 (4.8%) 5 (5.0%) 6 (4.6%)  
• > S$6,000 9 (3.9%) 5 (5.0%) 4 (3.1%)  
Dialysis vintage category    0.8b 
• 6-12 months 20 (8.5%) 9 (8.8%) 11 (8.3%)  
• 13-24 months 34 (14.5%) 16 (15.7%) 18 (13.5%)  
• > 24 months 181 (77.0%) 77 (75.5%) 104 (78.2%)  
Dialysis vintage, years 5.68 ± 4.76 5.83 ± 5.09 5.81 ± 4.53 0.9a 
Dialysis shift    0.7b 
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Mon-Wed-Fri 129 (54.9%) 57 (56.4%) 72 (53.7%)  
Tue-Thu Sat 106 (45.1%) 44 (43.6%) 62 (46.3%)  
Primary Cause of ESRD    0.7b 
• Glomerulonephritis 68 (28.9%) 27 (26.5%) 41 (30.8%)  
• Diabetic Nephropathy 61 (25.9%) 28 (27.5%) 33 (24.8%)  
• Hypertension 22 (9.4%) 9 (8.9%) 13 (9.7%)  
• Polycystic Kidney Disease 19 (8.1%) 9 (8.8%) 10 (7.5%)  
Charlson Comorbidity Index  4.89 ± 2.23 4.88 ± 2.19 4.90 ± 2.27 0.9a 
Kt/V 1.61 ± 0.20 1.63 ± 0.18 1.60 ± 0.22 0.4a 
nPCR g/kg/d 1.01 ± 0.26 1.01 ± 0.21 0.99 ± 0.30 0.6a 
Hemoglobin, g/dL 11.54 ± 1.47 11.55 ± 1.27 11.54 ± 1.61 0.9a 
Albumin, g/dL 34.81 ± 2.99 34.62 ± 3.03 34.95 ± 2.97 0.4a 
No. of medications 9.57 ± 3.65 9.67 ± 4.08 9.53 ± 3.62 0.9a 
Medication use     
Phosphate binders 209 (94.1%) 86 (91.5%) 122 (95.3%) 0.7b 
Calcium carbonate 80 (33.9%) 31 (30.7%) 49 (36.6%) 0.4b 
Calcium acetate 127 (53.8%) 55 (54.5%) 72 (53.7%) 0.7b 
Abbreviations: ESRD, end-stage renal disease; HED-SMART, Hemodialysis Self-Management Intervention 
Randomized Trial; nPCR, normalized protein catabolic rate. 
aUse of independent-samples t test.  
bUse of χ2-test.  
c N = 204 because 31 participants did not provide information on employment, 
d N = 189 because 14 participants ticked option “do not wish to answer” for income and 32 indicated “do not know.” 
dIncome brackets are equivalent to US dollars as follows: S$2,000 = US$1,600; S$4,000 = US$3,200; S$6,000 = 
US$4,800. The median monthly household income of the Singapore population was S$3,770 in 2014 (Ministry of 
Manpower, Singapore).33 
eUse of Fisher exact test because the number of expected count is less than 5. 
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Table 2 
Fit Indices for One- to Four-Class Unconditional Models for Depressive 
Symptoms 
Number 
of Classes 
Number of 
Parameters 
Log- 
Likelihood 
BIC 
BLRT 
p value 
Entropy 
1 6 -2387.32 4807.41 - - 
2 9 -2265.36 4579.85 < 0.001 .74 
3 12 -2218.00 4501.46 < 0.001 .79 
4 15 -2203.93 4489.76 < 0.001 .77 
Note. BIC = Bayesian Information Criterion; BLRT = Bootstrapped 
Likelihood Ratio Test. 
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Table 3 
Fit Indices for One- to Four-Class Unconditional Models for Anxious 
Symptoms 
Number 
of Classes 
Number of 
Parameters 
Log- 
Likelihood 
BIC 
BLRT 
p value 
Entropy 
1 6 -2479.97 4992.69 - - 
2 9 -2333.02 4715.17 < 0.001 .80 
3 12 -2299.09 4663.69 < 0.001 .78 
4 15 -2286.57 4655.04 < 0.001 .75 
Note. BIC = Bayesian Information Criterion; BLRT = Bootstrapped 
Likelihood Ratio Test. 
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Table 4 
Multinomial Logistic Regression for Sociodemographic and Medical Predictors of Latent Class 
Membership (N=218) 
 Depressive Symptoms  Anxious Symptoms 
 Low Stable a vs. High Stable  Low Stable a vs. High Stable 
 B SE p  B SE p 
Age -.082 .028 0.003  -.055 .021 0.009 
Gender        
Female -.227 .365 0.5  .288 .329 0.3 
Male 0 – –  0 – – 
Ethnicity        
Chinese 1.012 .370 0.006  .047 .325 0.9 
Non-Chinese b 0 – –  0 – – 
Marital Status        
Married -.411 .399 0.3  -.038 .347 0.9 
Not Married 0 – –  0 – – 
Education -.008 .330 0.9  -.013 .296 0.9 
Dialysis Vintage -.039 .038 0.3  -.085 .037 0.02 
Comorbidities .265 .106 0.01  .129 .089 0.1 
Notes. B = Logit, SE = Standard Error. 
a Reference Class. b Non-Chinese comprise Malay, Indian, and Other ethnic minorities. 
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Figure 1. Flowchart of Recruitment Process. 
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Figure 2. Estimated trajectories of depressive symptoms (Panel A) and anxious symptoms 
(Panel B). Latent Class Growth Analysis (LCGA) identified two substantively distinct groups 
of trajectories of depressive symptoms and anxious symptoms: low stable (■) and high stable 
(●). Within each group, HED-SMART intervention (continuous lines), as compared to usual 
care (dashed lines), was associated with reductions in depressive symptoms (p = .025) and 
anxious symptoms (p = .057). Scores ≥ 8 (dotted lines) signified caseness. 
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